A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations-Reference-Cited by-同舟云学术

A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations

Published:2019-01 Issue:1 Volume:12 Page:71-83
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Cohn Rachel,Thakar Ketan,Lowe Andre,Ladha Feria A.,Pettinato Anthony M.,Romano Robert,Meredith Emily,Chen Yu-Sheng,Atamanuk Katherine,Huey Bryan D.,Hinson J. Travis

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference43 articles.

1. Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy;Ashrafian;Circ. Res.,2011

2. β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations;Blankenburg;Circ. Res.,2014

3. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues;Boudou;Tissue Eng. Part A,2012

4. Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts;Bulkley;Circulation,1977

5. Cell-intrinsic functional effects of the alpha-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy;Chuan;Biophys. J.,2012

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward the latest advancements in cardiac regeneration using induced pluripotent stem cells (iPSCs) technology: approaches and challenges;Journal of Translational Medicine;2024-08-22

2. Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells;International Journal of Molecular Sciences;2024-08-09

3. Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy;Disease Models & Mechanisms;2024-08-01

4. Mitochondrial dysfunction in the pathogenesis of hypertrophic cardiomyopathy;Morphology;2024-07-30

5. Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy;iScience;2024-06